By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


European Commission (EC) 

Rue Joseph II
Jozef II straat 70
Brussels    B-1000  Belgium
Phone: n/a Fax: n/a


Medical Device

Company News
Exelixis (EXEL) Announces European Commission (EC) Approval Of COTELLIC (Cobimetinib) For Use In Combination With Vemurafenib In Advanced BRAF V600 Mutation-Positive Melanoma 11/25/2015 10:36:06 AM
IMPAX Labs (IPXL) Receives European Commission (EC) Marketing Authorization For NUMIENT (Levodopa And Carbidopa) Modified-Release Capsules For The Symptomatic Treatment Of Adult Patients With Parkinson's Disease 11/25/2015 6:28:05 AM
European Commission (EC) Approves Reconciliation Of Indications For Nivolumab Under The Opdivo European Marketing Authorization Application 11/24/2015 12:18:34 PM
European Commission (EC) Approves Amgen (AMGN)'s BLINCYTO (blinatumomab) For The Treatment Of Adults With Philadelphia Chromosome-Negative Relapsed Or Refractory B-Precursor Acute Lymphoblastic Leukemia 11/24/2015 6:12:05 AM
European Commission (EC) Grants Marketing Authorization For Gilead (GILD)’s Single Tablet Regimen Genvoya (Elvitegravir, Cobicistat, Emtricitabine And Tenofovir Alafenamide) For The Treatment Of HIV-1 Infection 11/23/2015 11:28:16 AM
The Medicines Company (MDCO) Receives European Commission (EC) Approval For IONSYS 40 Micrograms Per Dose Transdermal System (Fentanyl) To Treat Post-Operative Pain In Adult Hospitalized Patients 11/20/2015 11:59:47 AM
Zoetis (ZTS) Release: European Commission (EC) Approves Simparica, A Once-Monthly Chewable Flea And Tick Medication For Dogs 11/17/2015 10:50:56 AM
Celgene (CELG)’s VIDAZA (Azacitidine For Injection) Approved By European Commission (EC) As New Treatment For Elderly Patients With Acute Myeloid Leukaemia 10/30/2015 12:05:47 PM
European Commission (EC) Grants Orphan Medicinal Product Designation For CAT-1004, Catabasis Pharmaceuticals, Inc.’ Investigational Therapy For The Treatment Of Duchenne Muscular Dystrophy 10/26/2015 7:45:15 AM
AcelRx (ACRX) Reports That European Commission (EC) Has Granted Marketing Authorization For Zalviso For Treatment Of Acute Moderate-To-Severe Post-Operative Pain In Adult Patients 9/23/2015 10:32:21 AM